03Regulated work, unforgiving timelines.
Pharmaceutical and biotechnology
Development timelines are planned years out and defended in detail. The functions that protect them — safety, regulatory, quality, data — are staffed from a small and specialized population.
The challenge
A single unfilled role can move a submission date.
Pharmacovigilance backlogs, regulatory capacity and clinical data quality are not administrative concerns. They are the constraints that determine whether a timeline holds, and they are governed by expectations that are inspected rather than assumed.
What it usually looks like
- Scarce specialist talent across safety, regulatory and quality
- Case processing volumes that scale with product portfolio
- Validated systems that resist rapid change
- Data spread across sponsors, CROs, sites and vendors
- Continuous audit and inspection readiness
Our solution
Specialists, plus the data capability underneath them.
We recruit by function rather than by keyword — clinical operations, safety, regulatory and quality are separate professions with separate markets. Alongside that, we build the data engineering and automation that reduce the manual load those functions carry.
Talent we place
- Clinical Operations
- Clinical Data Management
- Pharmacovigilance
- Drug Safety
- Regulatory Affairs
- Quality Assurance
- Medical Writing
- Life Sciences Technology
Technology we build
- Clinical data engineering
- Safety data automation
- Intelligent document processing
- Analytics and reporting
- Validated cloud platforms
Potential use cases
Where an engagement usually starts.
- 01
Work down a case-processing backlog
Trained safety capacity scaled to volume, with a plan for what the steady state should be.
- 02
Add regulatory capacity for a submission
Specialist support through a compressed submission window without permanent overhead.
- 03
Reduce manual document handling
Automation and intelligent document processing applied where the volume is genuinely repetitive.
- 04
Unify clinical and operational data
Engineering across sponsor, CRO and site sources so reporting stops being reconciliation.
Services that apply
What this usually involves.
Next step
Let's talk about pharma & biotech.
Tell us how the work is organized where you are. That is where a useful conversation starts.